Helen Pentikis
Gründer bei Zero Point Five Therapeutics, Inc.
Ursprung des Netzwerks ersten Grades von Helen Pentikis
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Symbiomix Therapeutics LLC
Symbiomix Therapeutics LLC BiotechnologyHealth Technology Symbiomix Therapeutics LLC develops medicines for women’s health infections and related diseases. It offers SYM-1219, a drug that contains secnidazole that facilitate administration as a single-dose oral therapy for various women's health infections including bacterial vaginosis. The company was founded by Jack Roberts, Steve Pomerantz and Joseph L. Amprey III in 2012 and is headquartered in Newark, NJ.
4
| Subsidiary | Biotechnology | 4 |
Zero Point Five Therapeutics, Inc.
Zero Point Five Therapeutics, Inc. BiotechnologyHealth Technology Zero Point Five Therapeutics, Inc. is a drug development company that focuses on neglected tropical diseases and soil-transmitted helminthiasis. The company is based in Baltimore, MD. The company was founded by Helen S. Pentikis, Joseph L. Amprey. Joseph L. Amprey has been the CEO since incorporation.
3
| Holding Company | Biotechnology | 3 |
SAJE Pharma LLC
SAJE Pharma LLC Pharmaceuticals: MajorHealth Technology SAJE Pharma LLC operates as a biopharmaceutical company. It focuses on developing new therapeutic agents that provide significant benefits over available therapies for rare and common diseases with unmet medical needs. The company was founded by Matthews O. Bradley and Helen S. Pentikis in 2011 and is headquartered in Baltimore, MD.
1
| Holding Company | Pharmaceuticals: Major | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Helen Pentikis
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
RAYMOND JAMES FINANCIAL, INC. | Investment Managers | Private Equity Analyst | |
Lupin Investments Pvt Ltd. | Director/Board Member | ||
PRECIGEN, INC. | Biotechnology | Director/Board Member | |
PRECISION BIOSCIENCES, INC. | Biotechnology | Director/Board Member | |
REGENXBIO INC. | Pharmaceuticals: Major | Director/Board Member | |
Zyngenia, Inc.
Zyngenia, Inc. Drugstore ChainsRetail Trade Zyngenia, Inc. developed new class of bio-therapeutics. The company was founded by Joseph L. Amprey III, Carlos F. Barbas III and Peter Alec Kiener in 2008 and headquartered in Gaithersburg, MD. | Drugstore Chains | Founder | |
ULTRAGENYX PHARMACEUTICAL INC. | Pharmaceuticals: Major | Director/Board Member | |
Compass Therapeutics LLC
Compass Therapeutics LLC BiotechnologyHealth Technology Compass Therapeutics LLC operates as a healthcare industry focusing on biotechnology. It offers drug discovery, development, biologics, oncology and immuno-oncology. The company was founded by Errik B. Anderson and Thomas J. Schuetz in 2014 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
COGENT BIOSCIENCES, INC. | Biotechnology | Director/Board Member | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree | |
Vertex Partners
Vertex Partners Miscellaneous Commercial ServicesCommercial Services Part of Fair Isaac Corp., Vertex Partners is a consulting firm based in Boston, MA. The company provides consulting services in various fields such as strategy/IT and recruiting. Vertex Partners combines the knowledge of many companies to create new ventures and supports initiatives related to innovation and new business creation. Luce, a recruitment firm, is a subsidiary of Vertex Partners. Accuchain, a company that modernizes HR recruitment software, is also a part of Vertex Partners. The company was founded by Paul J. Bascobert. Vertex Partners was acquired by Braun Consulting, Inc. on May 11, 1999. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
LUPIN LIMITED | Pharmaceuticals: Other | Chief Executive Officer | |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Doctorate Degree | |
University of Mumbai | College/University | Undergraduate Degree | |
NEUROPACE, INC. | Medical Specialties | Director/Board Member | |
Novel Laboratories, Inc.
Novel Laboratories, Inc. Drugstore ChainsRetail Trade Novel Laboratories, Inc. manufactures and sells compressors. It also provides development and manufacturing services for other pharmaceutical research-based and generic pharmaceutical companies. The firm specializes in the development and manufacture of orally-disintegrating, liquid, modified-release, powder, and rectal dosage forms; immediate-release and chewable tablets, immediate-release and modified-release capsules, semi-solids, rectal gels, and rectal suppositories. The company was founded by Veerappan Sellappan Subramanian in December 2006 and is headquartered in Somerset, NJ. | Drugstore Chains | Director/Board Member | |
Kyowa Pharmaceutical Industry Co., Ltd.
Kyowa Pharmaceutical Industry Co., Ltd. Pharmaceuticals: MajorHealth Technology Kyowa Pharmaceutical Industry Co., Ltd. develops, manufactures, and markets pharmaceutical products. It offers tranquilizers, hypnotics, vasodilators, bronchial dilators, and anti-ulcer agents. The company was founded on January 29, 1954 and is headquartered in Osaka, Japan. | Pharmaceuticals: Major | Director/Board Member | |
Lupin Pharmaceuticals, Inc.
Lupin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lupin Pharmaceuticals, Inc. provides pharmaceutical products healthcare professionals and patients across geographies. The firm offers generic, specialty and active pharmaceutical ingredient drugs for diabetic, anti-inflammatory and respiratory therapy. The company was founded in 2003 and is headquartered in Baltimore, MD. | Pharmaceuticals: Major | Chief Executive Officer | |
DIMENSION THERAPEUTICS INC | Biotechnology | Chairman Founder | |
Kellogg School of Management | College/University | Masters Business Admin | |
Impresa Management LLC
Impresa Management LLC Investment ManagersFinance Impresa Management LLC(Impresa Management) is a Private Equity/Venture Capital firm, a subsidiary of Devonshire Investors LLC founded in 1946.The firm is headquartered in Boston. | Investment Managers | Private Equity Investor | |
Lupin GmbH
Lupin GmbH Miscellaneous Commercial ServicesCommercial Services Lupin GmbH provides management services. The private company is based in Schaffhausen, Switzerland. The CEO of the Swiss company is Vinita Deshbandhu Gupta. | Miscellaneous Commercial Services | Chief Executive Officer | |
OrbiMed Private Investments VI LP
OrbiMed Private Investments VI LP Investment ManagersFinance Orbimed Private Investments VI LP seeks investment opportunities companies located in North America and Europe. The fund targets companies operating in the fields of biopharmaceutical, medical device, diagnostics and healthcare services. It provides financing for seed stage, early stage, and later stage companies for both public and private companies with an investment size of $10 million to $75 million. | Investment Managers | Director/Board Member | |
Turnstone Biologics, Inc.
Turnstone Biologics, Inc. BiotechnologyHealth Technology Turnstone Biologics, Inc. develops bio-therapeutics for the treatment of cancer. It develops Maraba oncolytic viral immunotherapy, a platform representing a disruptive approach in the treatment of cancer. The company was founded by David Stojdl, Brian D. Lichty and John C. Bell and is headquartered in Ottawa, Canada. | Biotechnology | Director/Board Member Director/Board Member | |
Orchard Therapeutics (Europe) Ltd.
Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Orchard Therapeutics (Europe) Ltd. researches on transformative gene therapies. Its services include stem cell technology, gene therapy, eradicating orphan diseases, and paediatric diseases. The company was founded by Andrea Spezzi and Nicolas Koebel on September 1, 2015 and is headquartered in London, the United Kingdom. | Biotechnology | Chairman | |
XILIO THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Attenua, Inc.
Attenua, Inc. Pharmaceuticals: MajorHealth Technology Attenua, Inc. engages in the provision of biopharmaceutical services. The company was founded by Jing Liang and is headquartered in San Mateo, CA. | Pharmaceuticals: Major | Director/Board Member | |
Synchem Properties Pvt Ltd.
Synchem Properties Pvt Ltd. Real Estate DevelopmentFinance Synchem Properties Pvt Ltd. is an Indian company that leases and manages real estate properties. The private company was founded in 2015. The company is based in Mumbai, India. | Real Estate Development | Director/Board Member | |
Pionyr Immunotherapeutics, Inc.
Pionyr Immunotherapeutics, Inc. BiotechnologyHealth Technology Pionyr Immunotherapeutics, Inc. develops cancer immunotherapies. It targets the tumor microenvironment to enhance the body?s antitumor immunity. The company was founded by Max Krummel and Sachdev Sidhu in 2015 and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member | |
Lupin Atlantis Holdings SA
Lupin Atlantis Holdings SA Pharmaceuticals: MajorHealth Technology Part of Lupin Ltd., Lupin Atlantis Holdings SA is a holding Swiss company that manufactures and distributes pharmaceutical products. The company is based in Zug, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
Meves Pharmaceuticals, Inc.
Meves Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Meves Pharmaceuticals, Inc. provides pharmaceutical products and services. The company is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Modis Therapeutics, Inc.
Modis Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Modis Therapeutics, Inc. is a biopharmaceutical company, which develops disease-modifying therapies for rare genetic diseases. Its product MT1621 is in clinical development for thymidine kinase 2 deficiency (TK2d), an inherited mitochondrial disease. The company was founded by Peter H. Barber and Daniel D. DiPietro in 2016 and is headquartered in Oakland, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
TURNSTONE BIOLOGICS CORP. | Biotechnology | Director/Board Member | |
Lupin, Inc.
Lupin, Inc. Pharmaceuticals: MajorHealth Technology Part of Lupin Ltd., Lupin, Inc. is a pharmaceutical company. The company is based in Baltimore, MD. | Pharmaceuticals: Major | Chairman | |
Lupin Research, Inc.
Lupin Research, Inc. Pharmaceuticals: MajorHealth Technology Part of Lupin Ltd., Lupin Research, Inc. is a company that manufactures and commercializes pharmaceutical products. The company is based in Baltimore, MD. | Pharmaceuticals: Major | Director/Board Member | |
Lupin Management, Inc. | Director/Board Member | ||
Zyma Properties Pvt Ltd. | Director/Board Member | ||
Enliven Therapeutics, Inc. /US/
Enliven Therapeutics, Inc. /US/ BiotechnologyHealth Technology EnLiven Therapeutics, Inc. engages in the discovery and development of small molecule treatments for cancer. The company was founded by Samuel S. Kintz and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member | |
Charm Therapeutics Ltd.
Charm Therapeutics Ltd. BiotechnologyHealth Technology Charm Therapeutics Ltd. is a British London-based company that is discovering and developing small molecule medicines using its proprietary 3D deep learning-enabled platform, Dragonfold. The company aims to create life-changing therapies for difficult-to-drug targets in cancer and other disease areas. Charm Therapeutics has raised $70 million to date and is supported by high-quality international investors, including Orbimed, F-Prime Capital, General Catalyst, Khosla Ventures, Bristol Myers Squibb, NVIDIA, and Grep-VC. The company was founded in 2021 by Laksh Aithani and David Baker, with Laksh Aithani serving as the CEO since then. | Biotechnology | Director/Board Member | |
Avenue Coral Springs, LLC | Director/Board Member | ||
ENLIVEN THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Aer Therapeutics, Inc.
Aer Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aer Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in Raleigh, NC. The company's mission is to advance the treatment paradigm for mucus mediated lung diseases. The company is dedicated to delivering a therapeutic solution to patients suffering from muco-obstructive lung diseases, with their initial focus being on chronic obstructive pulmonary disease (COPD) and other muco-obstructive lung diseases to follow, including asthma, cystic fibrosis, and primary ciliary. The company was founded by John Fahy, and the CEO is Jim Shaffer. | Pharmaceuticals: Major | Director/Board Member | |
Charm Therapeutics, Inc. | Director/Board Member |
Statistik
International
Vereinigte Staaten | 39 |
Indien | 5 |
Vereinigtes Königreich | 4 |
Schweiz | 3 |
Japan | 2 |
Sektoral
Health Technology | 32 |
Finance | 5 |
Commercial Services | 5 |
Consumer Services | 5 |
Retail Trade | 3 |
Operativ
Director/Board Member | 79 |
Corporate Officer/Principal | 19 |
Independent Dir/Board Member | 14 |
Founder | 9 |
Chairman | 9 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Rishi Gupta | 29 |
Jodi S. Jahic | 25 |
Karen Dawes | 22 |
Benjamin Auspitz | 20 |
Vinita Deshbandhu Gupta | 18 |
Joseph Amprey | 9 |
Matthews O. Bradley | 2 |
- Börse
- Insiders
- Helen Pentikis
- Unternehmensverbindungen